ER was positive in 48% (15/31), PR in 35% (11/31), and AR in 68% (21/31) of the cancers in this category as shown in Table 1 and represented in Figs 2–4 for SCA, CCCA, and CS respectively. This evidence concerns the gene ESR1 and cancer.